Circulating TFH subset distribution is strongly affected in lupus patients with an active disease
about
Can follicular helper T cells be targeted to improve vaccine efficacy?Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients Naïve for TNF blockers.The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cellsConstitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritisImpaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity.Pathophysiology of T follicular helper cells in humans and miceAbnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infectionCirculating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain-Barré syndrome.Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficienciesActivated Circulating T Follicular Helper Cells Are Associated with Disease Severity in Patients with Psoriasis.Impaired T Cell-dependent Humoral Immune Response Associated with Juvenile-onset Recurrent Respiratory Papillomatosis ProgressionMetabolic Factors that Contribute to Lupus PathogenesisAngioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.Follicular T Cells from smB- Common Variable Immunodeficiency Patients Are Skewed Toward a Th1 PhenotypeT Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease.Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.Phenotype and functions of memory Tfh cells in human blood.Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus.Role of T Follicular Helper cells in Multiple Sclerosis.T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis.Follicular helper T cell in immunity and autoimmunityT follicular helper cells, interleukin-21 and systemic lupus erythematosus.Follicular T helper cells and humoral reactivity in kidney transplant patients.New insights into the immunopathogenesis of systemic lupus erythematosus.Antigen-presenting cell-derived IL-6 restricts the expression of GATA3 and IL-4 by follicular helper T cells.ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings.Increased cathepsin S in Prdm1-/- dendritic cells alters the TFH cell repertoire and contributes to lupus.Bob1 limits cellular frequency of T-follicular helper cells.Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon ActivityLoss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice.T Follicular Helper Cells in Transplantation: The Target to Attenuate Antibody-Mediated Allogeneic Responses?The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus.BAFF- and APRIL-targeted therapy in systemic autoimmune diseases.Distribution of circulating T follicular helper cell subsets is altered in immunoglobulin A vasculitis in children.Increased levels of CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells, and associated factors Bcl-6, CXCR5, IL-21 and IL-6 contribute to repeated implantation failure.Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.
P2860
Q26753848-5A931AB2-AB23-48E0-A005-5EB0D76758A2Q28067781-AAD867FA-A032-4C28-B653-2F2BF3C1AEDFQ34156020-5B72F19C-1937-4FC0-808D-D45E7FCF70B2Q34280534-83A4A0AC-5863-41BD-8132-621F97ACE30EQ34768971-621A11F9-3218-4F50-BF0F-23215643BEABQ35092312-1C330B91-692E-48BB-8E02-96B666435B9AQ35668403-B336BCB4-6822-4DD4-AE56-1F8716920139Q35695090-04764845-A90C-4E04-83D8-2E225A4C2585Q35848304-9E81D9F3-31CA-490F-AF0A-7DAE850F4FACQ36569933-CCA94C43-1F75-4AC1-A1DA-CD4B7EADD828Q37296295-84189ACB-5080-47CA-8CE8-746084A09E64Q37330183-82D8AE11-8E93-425A-B69E-50065814FFF5Q37399606-90C71E06-9A6B-43B8-8BE2-68AB3BFC2CFFQ37612885-008180A3-0BF3-41B5-A2C9-D175CECCC402Q37636149-2926314E-13E5-4B41-B914-7712004573A9Q37649641-98CB904D-C216-44C7-B7E6-54F069BEC247Q37667437-4EFBBF53-0BF3-4FEE-A95C-39CBAE8B4829Q37695317-756FA84F-6F76-40E7-A87E-3C71A0AFAE10Q38210794-3C96048E-1372-40C5-9D1D-C29B3B9006A2Q38226748-CC02637F-B3C2-4258-B321-694121D5656AQ38306720-45BD65DF-2004-4667-A926-71A32946560BQ38530157-6F4E4961-9FB0-4844-950A-920E2CADFD9FQ38650724-01413012-D4BC-4898-9C44-253FCA085299Q38812644-56D59BE3-331C-44CB-8928-DE79BFCBCC68Q38920904-63E80CAA-39E5-48A0-9C87-C98B665716AEQ38923388-77DED623-8E1D-4E54-9AD5-7E31F2AB64D5Q39016144-3E9D3B87-E7CD-4FC9-B979-4D217F464C64Q39543728-9D19DF55-8AB2-4CAB-A33F-AAE80351F74EQ39582808-7D897E6E-1A94-4E96-8E75-41A3F5855C70Q40141836-E68B2C79-F434-44E1-A678-70C3A321961AQ41607377-29A44956-81E9-460E-8C27-529E0831A648Q41692822-4E3F3E54-AFB8-4504-9675-220FFFB16DE7Q42149294-36DDF306-9421-4254-84F5-B3092AD93C1EQ42598296-E9DD1D1B-0917-4A92-9C48-8E1C07012D81Q43986231-2E1C3B39-57F6-4300-A79F-7A98183BD353Q47095865-190CBCD6-6FC0-4797-BB9C-2146310A11BCQ47100105-0EB6A418-0D66-4543-81B5-6FEE2ADF0487Q47248037-A470EA6F-1A49-4C0A-9471-8344A63CE469Q48321396-81DAC371-3C62-4B76-A882-B4B35D977AA7Q50640109-65ADF58B-23DD-42C7-8175-ECDEB50C4A33
P2860
Circulating TFH subset distribution is strongly affected in lupus patients with an active disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Circulating TFH subset distrib ...... atients with an active disease
@ast
Circulating TFH subset distrib ...... atients with an active disease
@en
Circulating TFH subset distrib ...... atients with an active disease
@nl
type
label
Circulating TFH subset distrib ...... atients with an active disease
@ast
Circulating TFH subset distrib ...... atients with an active disease
@en
Circulating TFH subset distrib ...... atients with an active disease
@nl
prefLabel
Circulating TFH subset distrib ...... atients with an active disease
@ast
Circulating TFH subset distrib ...... atients with an active disease
@en
Circulating TFH subset distrib ...... atients with an active disease
@nl
P2093
P2860
P1433
P1476
Circulating TFH subset distrib ...... atients with an active disease
@en
P2093
Anne-Sophie Korganow
Aurélie Joublin
Carole Le Coz
Fanny Monneaux
Hélène Dumortier
Jean-Louis Pasquali
P2860
P304
P356
10.1371/JOURNAL.PONE.0075319
P407
P577
2013-09-19T00:00:00Z